Agenda

VEA Newport Beach, A Marriott Resort & Spa

900 Newport Center Dr. Newport Beach, CA 92660

Explore What’s Next: Cardiovascular Tech Forum 2024 Agenda Coming Soon!

Get ready for CTF 2024 on Thursday, September 12th! While the 2024 agenda is under wraps, dive into the excitement of our 2023 Forum, where pioneers and visionaries shaped the future of cardiovascular health. Stay tuned for an even more compelling 2024 agenda, featuring cutting-edge advancements, dynamic speakers, and interactive sessions that redefine cardiovascular technology. Relive the 2023 highlights and prepare to embark on a journey into the future of cardiovascular care. The Cardiovascular Tech Forum 2024 agenda is coming soon – we can’t wait to share it with you!

 

Friday, September 15, 2023

7:30 – 8:00 am PST

EXPERIENCE

Registration 

8:00 – 8:45 am PST

EXPERIENCE

Partnership Pursuit (Invite Only)

9:00 – 9:15 am 

OPENING

Opening Remarks

Cheryl Wood, Senior Event Manager, Octane

Bill Carpou, CEO, Octane

Maria Berkman, MD, Head of MedTech, Broadview Ventures

9:15 – 9:40 am 

OPENING

Opening Keynote

Todd Brinton, MD, Chief Scientific Officer, Edwards Lifesciences; Founder & Medical Director, Shockwave

9:40 – 10:20 am 

PANEL

Innovations in Heart Failure Treatment

Defining the current needs. What are the most modern and efficient device products available in the market today? How are we advancing treatments in heart failure? What steps do you need to take in what order on the innovation pathway to new treatments? How do you define ownership and commercialize within your own company? When is the right time to approach funding to attract investor dollars and how to approach investors?

Dipti Itchhaporia, MD, FACC, Director of Disease Management, Hoag Heart and Vascular Institute (Moderator)

Terri Burke, Venture Partner, Epidarex Capital

Andrew Douglas, Partner, Knobbe Martens

Fabio M. Sagebin, MD, Surgical Director of Advanced Heart Failure and Mechanical Circulatory Support, UCI Medical Center

William C. Wilson, MD, MA, Executive VP, Clinical Operations and Medical Affairs, Past CMO at Masimo and UCI

10:20 – 10:35 am 

EXPERIENCE

Networking Break

10:35 – 11:20 am 

PANEL

Pediatric Innovation Development

Discussing the unique opportunities that are available when innovating for the pediatric population with a focus on human-centered design. How do the assumptions in the adult medical innovation pathway vary within pediatrics? Demonstrating the compelling value of ROI within pediatrics from all of the constituents. How do we accelerate pediatric innovation through investing models and collaborative initiatives?

Shareif Taraman, MD, CEO, Cognoa (Moderator)

Dustin Armer, CEO and Co-Founder, Renata Medical

Len Brandt, CEO, D2M Venture Development

Janene Fuerch, MD, Clinical Associate Professor, Stanford Children’s Health

Beverly Tang, Ph.D., CEO, Starlight Cardiovascular

11:20 am – 12:00 pm PT

PANEL

Changing the Trajectory of Heart Health Globally

How do we meet the increasing and changing needs with current resource constraints? How do we accelerate the speed of treatment or even more efficiently improve preventative care? How prevalent is AI in international care?

Celine Martin, Company Group Chairman, Cardiovascular and Specialty Solutions Group, Johnson & Johnson (Moderator)

Mazen Albaghdadi, MD, Director of Cardiac Catheterization Laboratory, Associate Director Cardiology Fellowship at the Naples Heart Institute; Medical Director of Madaktari Africa

Ramin Mousavi, President & CEO, CathWorks

Lars Sondergaard, MD, DMSc, FESC, Divisional Vice-President, Medical Affairs, Chief Medical Officer, Abbott Structural Heart

Cynthia Yee, Principal, Vensana Capital

12:00 – 1:00 pm PT

EXPERIENCE

Networking Lunch

1:00 pm – 1:45 pm 

PANEL

Aortic Disease

What are the current challenges and innovative solutions with aortic disease care? We have our ‘old way’, which is operating and open chest, but we are moving into more hybrid solutions. What are the innovative solutions within operative procedures themselves, as well as inoperative solutions?

Steve Hanle, Shareholder, Stradling (Moderator)

Joseph E. Bavaria, MD, Vice Chief, Division of Cardiovascular Surgery, PennMedicine, Founder/Co-Director, Penn Aorta Center

Shivanth Bhaskaran, Vice President Global Marketing, Aortic, Medtronic

Anthony Caffarelli, MD, Chief of Cardiac Surgery, Hoag

Jack Springer, CEO, Nectero Medical

1:45 – 2:45 pm 

PANEL

First-in-Humans

First-in-human trials serve as the link to advance new promising innovations from preclinical studies to initial human testing. What is the best pathway to first-in-human studies? How do you apply for first-in-humans in the United States? What are the pitfalls to avoid? Also, how are patient preferences factored into Clinical Studies in Cardiovascular Medicine? How are we taking into consideration the patient’s voice?

Jeff Daurity, Senior Director, Clinical Strategy and Operationalization, ICON (Moderator)

Adam Berman, CEO, Alleviant Medical, Inc.

William E Cohn, MD, Executive Director for the Center of Device Innovation at the Texas Medical Center

Saibal Kar, MD, Director of Structural Heart Disease and Research at HCA Healthcare

Arshad Quadri, MD, inQB8 Medical Technologies

2:45 – 3:15 pm 

EXPERIENCE

Networking Break

3:15 – 3:45 pm 

AWARD & KEYNOTE

Award & Keynote

Presented by Octane’s CEO, Bill Carpou, and inQBB Medical Technologies CEO, Dr. Arshad Quadri to:

William E Cohn, MD

 

3:45 – 5:15 pm 

COMPANY PRESENTATIONS

Capital and Growth Presenting Companies

Octane portfolio companies that have graduated from Octane’s LaunchPad SBDC accelerator will pitch their products to our investor ecosystem with key strategics and physicians.

Michael Hill, Managing Director, Capital Assist
Dave Beck, General Manager, Haystax.ai

Presenting Companies
Total Flow Medical
Stimore Medical Devices
SoundCath
ImaCor

Relief Cardiovascular

Judges
Haleh Armian, MSc, Director of Biomedical Innovation Ventures, Hoag
Duncan Fatkin, Chief Commercial Officer, Beyond Air Inc.
Virginia Giddings, PhD,
Vice President of Exploration, Edwards Lifesciences

Capital and Growth Awards and Closing Comments

Carol DiStanislao, Managing Director, Capital and Growth

 

5:15 – 8:00 pm PT

EXPERIENCE

Cocktail Reception – Grand Lawn

“Heart and Art” Reception

Women Leaders of Octane Quarterly Meeting (April 2024)

Virtual

Please join Women Leaders of Octane for our virtual quarterly meeting, Wednesday, April 17 from 12 – 1 pm PST, featuring our Spotlight Thought Leader, Sabina Pons, Managing Director, Growth […]

OC Innovation Week: Opening Reception

UCI Beall Applied Innovation 5270 California Ave # 100, Irvine, CA

Join us for the grand kickoff of OC Innovation Week at our Opening Reception, where excitement and innovation converge.

Contact Us

 

info@octaneoc.org

949.459.3366

4041 MacArthur Blvd, Suite 260 Newport Beach, CA 92660

 

© 2024 Octane